Bovilis BTV8
bluetongue virus serotype 8
Table of contents
Overview
The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
Authorisation details
| Product details | |
|---|---|
| Name |
Bovilis BTV8
|
| Agency product number |
EMEA/V/C/000148
|
| Active substance |
bluetongue virus vaccine, serotype 8 (inactivated)
|
| International non-proprietary name (INN) or common name |
bluetongue virus serotype 8
|
| Species |
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI04AA02
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Intervet International BV
|
| Revision |
4
|
| Date of issue of marketing authorisation valid throughout the European Union |
06/09/2010
|
| Contact address |
Wim de Körverstraat 35
5831 AN Boxmeer The Netherlands |
Product information
05/06/2015 Bovilis BTV8 - EMEA/V/C/000148 - R/0007
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Inactivated viral vaccines
-
bluetongue virus
-
SHEEP
Therapeutic indication
Cattle
To stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia
Sheep
To stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia